author-photo

Seigo Yukisawa

7

Papers

299

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial)

2019 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (8)
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial

2019 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (97)
Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer.

2016 Gastric Cancer
Show All
- Source
- Cite
- Save
Citations (46)
RAINBOW: A global, phase III, randomized, double-blind study of ramucirumab (RAM) plus paclitaxel (PTX) versus placebo (PL) plus PTX in the treatment of metastatic gastroesophageal junction and gastric adenocarcinoma (mGC) following disease progression on first-line platinum- and fluoropyrimidine-containing combination therapy--Efficacy analysis in Japanese and Western patients.

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (19)
Magnetic Resonance Imaging Findings in an Axillary Accessory Breast Fibroadenoma

2005 Breast Journal
Show All
- Source
- Cite
- Save
Citations (3)
Comparison of FDG PET and SPECT for Detection of Bone Metastases in Breast Cancer

2005 American Journal of Roentgenology
Show All
- Source
- Cite
- Save
Citations (120)